Cubist Systematic Strategies, LLC Ani Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$54.2 - $69.69 $1.19 Million - $1.53 Million	21,939 Added 65.02%	55,683 $3.85 Million
Q4 2023 Feb 14, 2024	BUY	$48.72 - $65.43 $251,395 - $337,618	5,160 Added 18.05%	33,744 $1.86 Million
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $1.26 Million - $1.62 Million	25,114 Added 723.75%	28,584 $1.66 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $129,209 - $186,520	-3,465 Reduced 49.96%	3,470 $186,000
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $260,825 - $317,068	6,935 New	6,935 $275,000
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $261,042 - $332,625	8,751 New	8,751 $281,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $696,134 - $1.22 Million	-25,869 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $852,900 - $1.47 Million	25,869 New	25,869 $1.19 Million
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $329,723 - $413,716	-12,499 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.93 - $50.1 $374,095 - $626,199	12,499 New	12,499 $404,000
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $185,286 - $409,889	-6,105 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $95,662 - $137,227	-1,719 Reduced 21.97%	6,105 $376,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $506,212 - $668,091	7,824 New	7,824 $570,000
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $357,703 - $550,564	-7,805 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $321,331 - $440,514	7,805 New	7,805 $351,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $1.02 Million - $1.23 Million	-18,027 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $1.03 Million - $1.31 Million	18,027 New	18,027 $1.05 Million

Others Institutions Holding ANIP

# of Institutions

210

Shares Held

18.2M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.01B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account